Plus   Neg

This Day That Year: OrthoPediatrics

op oct12 lt

Shares of OrthoPediatrics Corp. (KIDS) are down nearly 20% from their 52-week high of $39.81 recorded on October 5, 2018.

It was on this day last year, i.e. on October 12, 2017, that OrthoPediatrics debuted on the NASDAQ Global Market by setting a public offering at $13.00 per share.

OrthoPediatrics is a medical device company focused exclusively on pediatric orthopedics, which represents a $2.5 billion opportunity globally, including over $1.1 billion in the United States.

The Company currently markets 25 surgical systems that serve three of the largest categories within the pediatric orthopedic market namely, trauma and deformity, scoliosis, and sports medicine procedures. The products are sold in 38 countries and the United States.

The Company also has a deep pipeline of new systems that have demonstrated their ability to expand the addressable market.

As recently as May of this year, OrthoPediatrics received FDA clearance for Pediatric Nailing Platform, FEMUR, its 25th surgical system. The Company expects to launch four additional systems by year end.

Ever since inception, OrthoPediatrics has consistently delivered more than 20% revenue growth. Let's take a look at how the Company has fared in terms of its financial metrics over the years.

Gross Margin70%69.7%70.6%75.5%
Net Loss$9.55Mln$7.89Mln$6.57Mln$8.93Mln
Loss per Share$4.92$7.27$7.14$5.86

In the six months ended June 30, 2018, the Company incurred a net loss of $7.69 million or $0.62 per share on revenue of $27.17 million. This compared with a net loss of $2.55 million or $3.11 per share and revenue of $21.56 million in the year-ago period.

The Company ended June 30, 2018, with cash of $26.5 million.

Looking ahead to full-year 2018, OrthoPediatrics expects revenue growth to be in a range of 23% to 24% year-over-year.

KIDS has traded in a range of $14.00 to $39.81 over the last 1 year. The stock closed Thursday's trading at $31.98, down 3.65%.

For comments and feedback contact: editorial@rttnews.com

Business News

Follow RTT